Kestra Medical Technologies (KMTS) Equity Average (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Equity Average data on file, last reported at $226.0 million in Q1 2026.

• Equity Average for Q1 2026 came in at $226.0 million, up 191.43% year-over-year; the trailing twelve-month figure through Jan 2026 was $226.0 million (up 191.43% YoY), and the FY2025 annual result was -$2.0 million, changed N/A from the prior year.
• Equity Average climbed to $226.0 million in Q1 2026 per KMTS's latest filing, from $174.1 million in the prior quarter.
• Over five years, Equity Average peaked at $226.0 million in Q1 2026 and troughed at -$247.2 million in Q1 2025.
• A 3-year average of -$39.5 million and a median of -$112.3 million in 2024 frame the typical range for Equity Average.
• On a YoY basis, Equity Average climbed as much as 191.48% in 2025 and fell as far as 86.77% in 2025.
• A 3-year view of Equity Average shows it stood at -$226.5 million in 2024, then surged by 176.87% to $174.1 million in 2025, then climbed by 29.82% to $226.0 million in 2026.
• Business Quant data shows KMTS's Equity Average at $226.0 million in Q1 2026, $174.1 million in Q4 2025, and $194.8 million in Q3 2025.